Wedbush Securities’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-36,239
| Closed | -$100K | – | 1119 |
|
|
2021
Q4 | $100K | Buy |
+36,239
| New | +$100K | ﹤0.01% | 1127 |
|
|
2020
Q4 | – | Sell |
-20,900
| Closed | -$32K | – | 888 |
|
|
2020
Q3 | $32K | Sell |
20,900
-2,000
| -9% | -$3.06K | ﹤0.01% | 907 |
|
|
2020
Q2 | $43K | Hold |
22,900
| – | – | ﹤0.01% | 917 |
|
|
2020
Q1 | $39K | Sell |
22,900
-17,800
| -44% | -$30.3K | ﹤0.01% | 836 |
|
|
2019
Q4 | $118K | Sell |
40,700
-20,700
| -34% | -$60K | 0.01% | 916 |
|
|
2019
Q3 | $39K | Buy |
61,400
+400
| +0.7% | +$254 | ﹤0.01% | 948 |
|
|
2019
Q2 | $59K | Sell |
61,000
-500
| -0.8% | -$484 | 0.01% | 938 |
|
|
2019
Q1 | $85K | Sell |
61,500
-1,800
| -3% | -$2.49K | 0.01% | 867 |
|
|
2018
Q4 | $68K | Sell |
63,300
-12,250
| -16% | -$13.2K | 0.01% | 781 |
|
|
2018
Q3 | $465K | Buy |
+75,550
| New | +$465K | 0.05% | 428 |
|
|
2018
Q1 | – | Sell |
-48,812
| Closed | -$342K | – | 833 |
|
|
2017
Q4 | $342K | Buy |
48,812
+19,500
| +67% | +$137K | 0.04% | 501 |
|
|
2017
Q3 | $256K | Buy |
+29,312
| New | +$256K | 0.03% | 615 |
|